Antipsychotics Explained: How They Treat Schizophrenia and Bipolar Disorder

If you or someone you know is in crisis, the 988 Suicide & Crisis Lifeline (988lifeline.org) is available 24/7 by call or text.

Antipsychotic medication is often introduced through the lens of a single condition, but the same drugs genuinely treat both schizophrenia and bipolar disorder through mechanisms that overlap considerably more than most people realize. This guide covers how antipsychotics actually work and the real difference between the two generations of the drug class.

One Drug Class, Two Conditions

Our conditions page covers schizophrenia and bipolar disorder as separate conditions, each with its own distinct diagnostic criteria and symptom pattern; this article focuses specifically on the medication class that treats both, since the overlap in treatment is genuinely larger than the overlap in how the two conditions actually present clinically.

Antipsychotics work primarily by blocking dopamine receptors in the brain, reducing the excess dopamine activity linked to hallucinations and delusions in schizophrenia specifically. That same mechanism, and several additional ones layered on top of it in newer drugs, also stabilizes the manic episodes that characterize bipolar I disorder, which is exactly why the same medications show up in the treatment plan for both conditions rather than one dedicated drug class existing per diagnosis, the way many people initially assume.

This overlap surprises people who assume a medication must be built for one specific condition, but psychiatric drug classes routinely cross diagnostic lines this way, and antipsychotics are one of the clearest examples of that pattern in practice. The dopamine and serotonin pathways these drugs act on are not organized around diagnostic categories to begin with; they are shared biological systems that misfire in somewhat different but genuinely overlapping ways across several distinct psychiatric conditions, which is exactly why a single drug can meaningfully help with more than one.

Read More: Mental Health Disorders: Symptoms, Causes, Diagnosis, and Treatment

Typical vs. Atypical: Why the Distinction Matters

The first antipsychotics, developed in the 1950s and now called typical antipsychotics, work almost exclusively by blocking dopamine, which controls hallucinations and delusions well but carries a real, well-documented risk of movement-related side effects, such as tremor, muscle stiffness, and restlessness, along with tardive dyskinesia, involuntary movements that can become permanent even after the medication stops. Newer atypical antipsychotics, which came into widespread use in the 1990s, block both dopamine and serotonin receptors together, a broader mechanism that may help somewhat more with negative symptoms such as apathy and social withdrawal, while generally carrying a lower risk of movement side effects; several atypicals, however, carry a higher risk of weight gain, blood sugar, and cholesterol changes.

Four Atypical Antipsychotics

Four atypical antipsychotics are available, each with a genuinely different side-effect profile despite sharing the same broad drug class and overall mechanism of action.

• Aripiprazole, a partial dopamine agonist rather than a pure blocker, meaning it activates dopamine receptors partially rather than blocking them outright; generally associated with less weight gain and sedation than the other three, often a reasonable starting point for that specific reason, though it can cause akathisia, an uncomfortable inner restlessness worth reporting

• Quetiapine is genuinely sedating at typical doses, which makes it useful when sleep disruption is part of the overall clinical presentation, but also means daytime drowsiness is a real, practical consideration for anyone with a demanding daily schedule or work requiring sustained alertness; it also carries a moderate risk of weight gain and metabolic changes, and can cause dizziness on standing

• Olanzapine is generally very effective for acute symptoms and often used when rapid symptom control matters most, but carries the strongest association with weight gain and metabolic changes among the four, requiring closer ongoing monitoring of blood sugar and cholesterol over time

• Risperidone is effective across a genuinely broad symptom range with a moderate side-effect profile overall, and one of the more extensively studied options in both adult and adolescent populations specifically, giving prescribers a particularly deep, well-established evidence base to draw on when weighing options; it raises prolactin more than most atypicals, which can cause breast changes, menstrual irregularities, or sexual side effects, and its risk of movement side effects rises at higher doses

None of these four is universally "best," and a prescriber choosing between them is not picking a hierarchy of effectiveness so much as matching a specific side-effect profile to a specific person’s priorities and health history. The right choice depends heavily on which side effects matter most for a given person: sedation, weight, or movement symptoms, since all four control core symptoms reasonably well when dosed appropriately and given adequate time to work.

Where to Start

If weight gain, sedation, or movement symptoms are a genuine concern with a current antipsychotic, that specific concern is worth naming directly to a prescriber, since switching between these four options is a common and often straightforward way to address a side effect without abandoning treatment altogether or losing the symptom control already achieved. Never stop an antipsychotic abruptly without medical guidance, since doing so carries a real, well-documented risk of relapse. All atypical antipsychotics call for baseline and periodic checks of weight, blood sugar, and cholesterol. A rare but serious reaction, neuroleptic malignant syndrome, causes high fever, severe muscle rigidity, and confusion and needs emergency care. Antipsychotics also carry an FDA boxed warning about increased risk of death in older adults with dementia-related psychosis, a use they are not approved for.

It is also worth asking specifically which condition a prescribed antipsychotic is targeting, schizophrenia, bipolar mania, or something else entirely, since the same medication can be part of genuinely different treatment plans depending on the underlying diagnosis, and understanding which applies helps make sense of the overall treatment strategy, including how long treatment is expected to continue and what improvement should realistically look like over time.

Our conditions page covers the broader picture of both schizophrenia and bipolar disorder that this medication class treats.

Read More: Mental Health Disorders: Symptoms, Causes, Diagnosis, and Treatment